Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aranesp Fallout: Managed Care May Follow CMS In “Functional Equivalence”

Executive Summary

Managed care organizations may start using functional equivalence as a tool in determining coverage levels, biotech companies agreed during a panel presentation at the Kellogg Biotech Conference in Chicago April 5

You may also be interested in...



Biologic “Functional Equivalence” Being Considered By Insurers – WellPoint

Managed care plans increasingly are moving toward selecting preferred biologic agents within a therapeutic class, WellPoint VP & Chief Pharmacy Officer Robert Seidman said

Biologic “Functional Equivalence” Being Considered By Insurers – WellPoint

Managed care plans increasingly are moving toward selecting preferred biologic agents within a therapeutic class, WellPoint VP & Chief Pharmacy Officer Robert Seidman said

“Functional Equivalence” Battle Has Just Begun, Sen. Hatch Aide Says

Reimbursement for biologics will come under increased scrutiny with the passage of a Medicare drug benefit, Sen. Orrin Hatch's Legislative Assistant Bruce Artim predicts

Related Content

UsernamePublicRestriction

Register

OM007016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel